These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10917406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R, Mölle M, Fehm HL, Born J.
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue.
    Wellhöner P, Hörster R, Jacobs F, Sayk F, Lehnert H, Dodt C.
    Int J Obes (Lond); 2012 May; 36(5):703-8. PubMed ID: 21629206
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
    Hallschmid M, Benedict C, Schultes B, Perras B, Fehm HL, Kern W, Born J.
    Regul Pept; 2008 Aug 07; 149(1-3):79-83. PubMed ID: 18442862
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG, Willard DH, Wilkison WO.
    Endocrinology; 1999 May 07; 140(5):2167-72. PubMed ID: 10218968
    [Abstract] [Full Text] [Related]

  • 10. Effects of ORG-2766 on brain event-related potentials of autistic children.
    Verbaten MN, Kemner C, Buitelaar JK, van Ree JM, van Beijsterveld CE, van Engeland H.
    Psychiatry Res; 1996 Jun 26; 63(1):33-45. PubMed ID: 8832772
    [Abstract] [Full Text] [Related]

  • 11. Adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides modulate adenylate cyclase activity in rat brain slices: evidence for an ACTH/MSH receptor-coupled mechanism.
    Florijn WJ, Mulder AH, Versteeg DH, Gispen WH.
    J Neurochem; 1993 Jun 26; 60(6):2204-11. PubMed ID: 8388034
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.
    Moustafa M, Szabo M, Ghanem GE, Morandini R, Kemp EH, MacNeil S, Haycock JW.
    J Invest Dermatol; 2002 Dec 26; 119(6):1244-53. PubMed ID: 12485424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pituitary changes of desacetyl-alpha-melanocyte-stimulating hormone throughout development.
    Facchinetti F, Storchi AR, Furani S, Radi D, Genazzani AR.
    Biol Neonate; 1988 Dec 26; 54(2):86-92. PubMed ID: 2844314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alpha-melanocyte-stimulating hormone and behavior.
    Datta PC, King MG.
    Neurosci Biobehav Rev; 1982 Dec 26; 6(3):297-310. PubMed ID: 6294567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.